Certara stock.

Total cost of revenue for the third quarter of 2023 was $35.9 million, an increase of $3.1 million from $32.8 million in the third quarter of 2022, primarily due to a $3.0 million increase in ...Q3 2023 Certara Inc Earnings Call. Find the latest Certara, Inc. (CERT) stock quote, history, news and other vital information to help you with your stock trading and investing.The high in the last 52 weeks of Certara stock was 24.95. According to the current price, Certara is 58.68% away from the 52-week high. What are analysts …Certara is committed to understanding, monitoring, and managing our social and environmental responsibilities. Regulatory Adoption. Many global regulatory agencies have adopted use of Certara’s Simcyp PBPK and Phoenix PK/PD platforms. ... Inclusion of Pre-test/Stock Animals in the SEND Dataset.

The estimated net worth of Robert Aspbury is at least $5.51 million as of June 14th, 2021. Dr. Aspbury owns 375,451 shares of Certara stock worth more than $5,511,621 as of November 28th. This net worth estimate does not reflect any other investments that Dr. Aspbury may own.

PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is ...Dec 1, 2023 · Latest Software and Docebo Inc, Certara Inc Stock News. As of December 1, 2023, Docebo Inc had a $1.9 billion market capitalization, compared to the Software median of $398.3 million. Docebo Inc’s stock is NA in 2023, NA in the previous five trading days and up 41.82% in the past year. Currently, Docebo Inc does not have a price-earnings ratio.

A. The latest price target for Certara ( NASDAQ: CERT) was reported by Stephens & Co. on Wednesday, October 11, 2023. The analyst firm set a price target for 20.00 expecting CERT to rise to within ...Certara Inc stock has a Value Score of 15, Momentum Score of 49 and Estimate Revisions Score of 29. Comparing Samsara Inc and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.1.53. +0.02. +1.66%. Get Certara Inc (CERT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Certara (CERT) stock rose ~15% on Thursday after Q4 results beat estimates and the company's FY23 outlook range surpassed analysts expectations.Adjusted EPS grew +166.6% Y/Y to $0.16,...Nov 24, 2023 · View Certara, Inc CERT investment & stock information. Get the latest Certara, Inc CERT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Step 1: Check Ratings History. In the short term, look to see whether analysts suggest an initiation, upgrade or downgrade for a particular stock. Understand how the rating changed compared to the ...

The average twelve-month price prediction for Palantir Technologies is $13.25 with a high price target of $25.00 and a low price target of $5.00. Learn more on PLTR's analyst rating history. Do Wall Street analysts like Palantir Technologies more than its competitors? Analysts like Palantir Technologies less than other Business Services …

Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...Reiterating 2023 Financial Outlook. Certara continues to expect the following: Full year 2023 revenue to be in the range of $370 million to $385 million. Full year 2023 adjusted EBITDA to be in the range of $131 million to $137 million. Full year adjusted diluted earnings per share to be in the range of $0.50 - $0.55.The estimated Net Worth of Richard M. Traynor is at least $10.2 Million dollars as of 6 March 2023. Mr Traynor owns over 10,000 units of Certara stock worth over $4,562,422 and over the last 2 years he sold CERT stock worth over $5,603,360.Certara went public in December 2020, raising $337 million in an IPO. The firm sells biosimulation software and related services to biopharmaceutical firms and regulatory agencies worldwide. CERT ...The estimated Net Worth of William F Feehery is at least $78.7 Millón dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $45,530,211 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.

Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. The Investor Relations website contains information about Certara, Inc.'s business for stockholders, potential investors, and financial analysts.Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screensNov 23, 2023 · Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price-earnings ratio. Certara Inc’s trailing 12-month revenue is $353.0 million with a -9.6% net profit margin. Year-over-year quarterly sales growth most recently was 1.1%. Certara Inc. 1699 South Hanley Road. St. Louis, Missouri 63144-2319. Phone 314 647-1099. Industry Software. Sector Technology. Fiscal Year-end N/A. Revenue.Certara Inc Registered Shs Aktie Profil Die Certara Inc Registered Shs Aktie wird unter der ISIN US15687V1098 an den Börsen Hamburg, Berlin, NASDAQ, Bats, NASDAQ Bsc, Tradegate und Lang & Schwarz ...

From Nasdaq : Certara, which provides biosimulation software and services used for drug development, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. However, this is likely a placeholder for a deal we estimate could raise up to $500 million. The company uses its biosimulation software and technology to ...Nov 11, 2022 · Certara ( CERT -1.83%), which provides software and technology to help pharmaceutical companies and researchers accelerate drug development, saw its shares rise 37.7% this week. The stock closed ...

Why Certara. Responsibility. Certara is committed to understanding, monitoring, and managing our social and environmental responsibilities. Regulatory Adoption. Many global regulatory agencies have adopted use of Certara’s Simcyp PBPK and Phoenix PK/PD platforms. Locations. Discover our global office locations. LeadershipGet the latest information on Certara, Inc. (CERT) stock, including its performance, outlook, earnings, dividends, and insider transactions. See how CERT stock compares to other medical AI companies and the healthcare industry. CERT Stock Overview. Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. About the company. CERT fundamental analysis. Snowflake Score. Valuation. 1 /6. Future Growth.November 15, 2021. PRINCETON, N.J.– November 15, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering by certain selling stockholders of 10 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission.Mar 17, 2023 · In terms of valuation, Certara Inc. stock appears to be trading at a premium compared to its peers in the same industry. The company's market capitalization stands at approximately $3.1 billion ... Oct 17, 2023 · With Certara, Inc. shares trading a bit north of 30 times earnings and nearly 6.5 times forward sales, there is nothing compelling about the stock's current valuation given Certara's projected ... Q3 2023 Certara Inc Earnings Call. Find the latest Certara, Inc. (CERT) stock quote, history, news and other vital information to help you with your stock trading and investing.Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private Equity. PRINCETON, N.J.— December 8, 2022 — Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and building transformational healthcare companies, …The Nasdaq Stock Market LLC Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing …

A. The latest price target for Certara ( NASDAQ: CERT) was reported by Stephens & Co. on Wednesday, October 11, 2023. The analyst firm set a price target for 20.00 expecting CERT to rise to within ...

Nov 22, 2021 · PRINCETON, N.J.—November 22, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 10,000,000 shares of its common stock by certain existing stockholders at a public offering price of $31.00 per share.

The estimated Net Worth of Leif E Pedersen is at least $6.02 Million dollars as of 31 March 2023. Mr Pedersen owns over 8,646 units of Certara stock worth over $3,161,396 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock ...FDA holds more than 400 Simcyp™ and Phoenix™ software licenses across 12 divisions and officesPRINCETON, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader ...Nov 23, 2023 · Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price-earnings ratio. Certara Inc’s trailing 12-month revenue is $353.0 million with a -9.6% net profit margin. Year-over-year quarterly sales growth most recently was 1.1%. Total cost of revenue for the third quarter of 2023 was $35.9 million, an increase of $3.1 million from $32.8 million in the third quarter of 2022, primarily due to a $3.0 million increase in ...Patrick Smith CERT stock SEC Form 4 insiders trading. Patrick has made over 6 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Patrick sold 19,104 units of CERT stock worth $411,691 on 5 June 2023.19,104 units of CERT stock worth $411,691 on 5 June 2023.Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT.Open $0.9454. Day Range 0.9230 - 1.0100. 52 Week Range 0.7078 - 1.6300. Market Cap $454.63M. Shares Outstanding 399.78M. Public Float 370.52M. Beta 1.69. Rev. per Employee $3.692M. P/E Ratio N/A.Download Version 8.4. Reach Your Professional Development Goals. Certara University provides on-demand and on-site courses. Our programs are designed for novice and advanced users in the area of pharmacokinetic (PK) and pharmacodynamics (PD) and are taught using Certara software including the industry-standard software Phoenix …

54.33%. Get the latest Certara Inc (CERT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Webull offers Certara Inc stock information, including NASDAQ: CERT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERT stock news, and many more online research tools …Certara CERT has an Earnings ESP of +5.41% and sports a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here. Certara is set to report its first-quarter ...1.34%. $25.98M. Plains All American Pipeline L.P. 1.86%. $10.93B. TELL | Complete Tellurian Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Instagram:https://instagram. mobile expense tracking appvanguard high yield bondcyclical stocks listapps stock forecast Mar 24, 2021 · Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (“the selling stockholders”) at a price to the public of $25.00 per share. Additionally, the selling stockholders have granted the ... 54.33%. Get the latest Certara Inc (CERT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … how to use paper trading on webullcognac vs armagnac 5.27 M Change from Last -18.62% Percent of Float 4.84% Research & Ratings Certara Inc. Per-Share Earnings, Actuals and Estimates Actual Analyst Range Consensus More View the latest Certara Inc.... is silver a good investment now The estimated Net Worth of Leif E Pedersen is at least $6.02 Million dollars as of 31 March 2023. Mr Pedersen owns over 8,646 units of Certara stock worth over $3,161,396 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.The Nasdaq Stock Market LLC Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing …What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ...